Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Indian Med Assoc ; 2000 Feb; 98(2): 68-70
Article in English | IMSEAR | ID: sea-101206

ABSTRACT

The present study was undertaken to study the comparative safety and efficacy of two cough formulas viz, Ascoril expectorant and other cough formula in the management of cough associated with respiratory disorders. Fifty patients having cough associated with various respiratory disorders like bronchitis and upper or lower respiratory tract infections were randomly divided into 2 equal groups and were treated with one of the two cough formulas viz, Ascoril cough formula and other cough formula in double-blind manner over a period of 15 days. The evaluation of improvement was carried out by a rating scale using three clinical parameters--cough, sputum and breathlessness. The physicians were asked to rate the effectiveness of the therapy and patients were asked to rate the acceptability of therapy using pre-defined operational criteria. It was observed that the improvement and symptom relief was almost immediate, quicker and better in the group receiving Ascoril as compared to other group. On effectiveness parameter, 96% of the physicians rated Ascoril as having either 'very high effectiveness or high effectiveness' as opposed to only 34% of the physicians who rated other cough formula as having 'high' or 'very high effectiveness'. While on parameter of acceptability, 96% of the patients rated acceptability of Ascoril as 'high' or 'good' as opposed to only 24% of the patients who rated other cough formula 'high' or 'good'. The findings of this study suggests that Ascoril cough formula has better efficacy as well as better patient acceptability. Thus, Ascoril cough formula is superior to other cough formula in management of cough associated with respiratory disorders.


Subject(s)
Adolescent , Adult , Albuterol/administration & dosage , Ammonium Chloride/administration & dosage , Bromhexine/administration & dosage , Child , Child, Preschool , Citrates/administration & dosage , Cough/drug therapy , Diphenhydramine/administration & dosage , Double-Blind Method , Drug Combinations , Expectorants/administration & dosage , Female , Guaifenesin/administration & dosage , Humans , Male , Prospective Studies , Treatment Outcome
2.
Medicina (B.Aires) ; 59(1): 38-42, 1999. tab, graf
Article in English | LILACS | ID: lil-231908

ABSTRACT

The objective of this paper was to evaluate the efficacy of diphenhydramine hidrochloride (DPH) in dystonic patients. In 1995, Truong et al reported encouraging results in five patients with idiopathic torsion dystonia (ITD) treated with DPH, an H1 antagonist with sedative and anticholinergic properties. Five patients with generalized ITD, one with secondary generalized dystonia and one with idiopathic segmental dystonia were included in the prospective study, initialy the response to intravenous administration of DPH versus placebo in two sessions a week apart was evaluated. Two weeks later all patients started oral DPH in increasing doses (range 100-300 mg, mean 164 mg). The degree of dystonia was determined by a modified University of Columbia Scale evaluating the baseline score, after placebo and DPH I.V. administration then at one and six months after starting oral treatment. The results were analyzed by Friedman's test for repated measurements. On comparing scores for baseline severity, I.V. placebo and I.V. DPH presented a highly significant correlation (12.09; p = 0.00) as well as comparing baseline score with oral DPH at one and 6 months, treatment (12.78; p = 0.00). Functional score results were 9.5 p = 0.01 and 8.4 p = 8.4 p = 0.02 at one and 6 months respectively. The most common side effects were sommolence and dizziness. It can be concluded that DPH proved effective in our patients with mild to moderate adverse effects not requiring drug withdrawal in any case. However, I.V. challenge was unable to predict the long-term response to oral medication perhaps due to the limited number of cases.


Subject(s)
Female , Humans , Adult , Middle Aged , Child , Adolescent , Diphenhydramine/therapeutic use , Dystonia/drug therapy , Histamine H1 Antagonists/therapeutic use , Diphenhydramine/administration & dosage , Double-Blind Method , Histamine H1 Antagonists/administration & dosage , Prospective Studies , Severity of Illness Index
3.
Indian J Exp Biol ; 1998 Jun; 36(6): 578-82
Article in English | IMSEAR | ID: sea-57486

ABSTRACT

Transdermal permeation of positively charged liposomally entrapped diphenhydramine hydrochloride (DPH-HCL) has been investigated in presence of pulse D.C. anodic current. Positively charged liposomes were prepared by lipid film hydration technique with stearyl amine as a charge inducer. The prepared liposomes were then subjected to in vitro permeation studies using artificial membrane (cellophane membrane) and human cadaver skin under the influence of iontophoretic current. The effect of variable current density as well as time frequency of application of current onto the release pattern of the plain drug and charged liposomally entrapped drug were studied and the results were compared. The results indicate that application of pulse D.C. anodic current significantly influences the transfer of positively charged liposomally entrapped DPH-HCL across HCS.


Subject(s)
Diphenhydramine/administration & dosage , Drug Carriers , Histamine H1 Antagonists/administration & dosage , Humans , Liposomes , Skin Absorption
4.
Indian J Physiol Pharmacol ; 1997 Jan; 41(1): 42-6
Article in English | IMSEAR | ID: sea-106784

ABSTRACT

Effect of diphenhydramine was investigated on withdrawal signs in lorazepam dependent rats. Physical dependence was produced by giving lorazepam admixed with the food in the following dose schedule: 10 x 4, 20 x 4, 40 x 4, 80 x 4 and 120 x 7 (mg/kg, daily x days). The parameters observed during the periods of administration of lorazepam and after its withdrawal were spontaneous locomotor activity (SLA), body temperature, reaction time to pain, foot shock aggression (FSA) and audiogenic seizures. Diphenhydramine was administered orally in the dose schedules of once daily (10, 20 and 40 mg/kg) and twice daily (5, 10 and 20 mg/kg) in separate groups during the withdrawal period. The withdrawal signs observed in control group (without diphenhydramine) were hyperkinesia, hyperthermia, hyperaggression and audiogenic seizures. Hyperkinesia and hyperthermia were blocked in all the groups of diphenhydramine-treated rats. FSA was inhibited only by diphenhydramine (10 and 20 mg/kg) given twice daily. Audiogenic seizures were completely blocked by once daily (20 and 40 mg/kg) as well as twice daily (20 mg/kg) doses of diphenhydramine. It may be concluded that diphenhydramine exerts a protective effects on benzodiazepine withdrawal syndrome.


Subject(s)
Acoustic Stimulation , Administration, Oral , Aggression/drug effects , Animals , Anti-Anxiety Agents/adverse effects , Body Temperature/drug effects , Diphenhydramine/administration & dosage , Female , Hypnotics and Sedatives/administration & dosage , Lorazepam/adverse effects , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Seizures/etiology , Substance Withdrawal Syndrome/drug therapy
5.
Indian J Physiol Pharmacol ; 1995 Apr; 39(2): 163-5
Article in English | IMSEAR | ID: sea-106463

ABSTRACT

The antimuscarinic activity of oxyphenonium bromide, diphenhydramine hydrochloride and astemizole were evaluated in six volunteers. The parameters used were salivary secretion, heart rate and pupillary size. The results indicated that the changes in heart rate and pupillary size and measurements were not convenient parameters for class room demonstration. However, salivary secretion and dryness of mouth were found to be reliable parameters for measurement. It was concluded that simple procedures like evaluation of antimuscarinic activity could be introduced as teaching aids in clinical pharmacology for undergraduate students.


Subject(s)
Adult , Astemizole/administration & dosage , Diphenhydramine/administration & dosage , Education, Medical/standards , Heart Rate/drug effects , Humans , Male , Muscarinic Antagonists , Oxyphenonium/administration & dosage , Pupil/drug effects , Salivation/drug effects , Students, Medical
SELECTION OF CITATIONS
SEARCH DETAIL